Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 259.80
+4.20 (1.64%)
May 7, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 23.08 billion as of May 7, 2026.
Market Cap
23.08B
Enterprise Value
19.50B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
259.80
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 23.08B, an increase of 31.80%. That is a compound annual growth rate of 29.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 23.08B | -13.43% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Junshi Biosciences | 42.02B |
| Shanghai Henlius Biotech | 40.57B |
| Genscript Biotech | 29.12B |
| InnoCare Pharma | 27.77B |
| Keymed Biosciences | 21.79B |
| TransThera Sciences (Nanjing) | 21.54B |
| Zai Lab | 18.68B |
| Ascletis Pharma | 17.93B |